Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-04T21:15:09.350Z Has data issue: false hasContentIssue false

23 - Treatment of nicotine dependence

from Part III - Specific treatments

Published online by Cambridge University Press:  12 May 2010

By
Andrea H. Weinberger ,
Pamela Walters ,
Taryn M. Allen ,
Melissa M. Dudas ,
Kristi A. Sacco  and
Tony P. George
Edited by
Peter Tyrer  and
Kenneth R. Silk
Andrea H. Weinberger
Affiliation:
Department of Psychiatry Yale University Medical School of Medicine New Haven, CT USA
Pamela Walters
Affiliation:
Camlet Lodge Regional Secure Unit Chase Farm Hospital The Ridgeway Enfield London UK
Taryn M. Allen
Affiliation:
Department of Psychiatry Yale University School of Medicine USA
Melissa M. Dudas
Affiliation:
New York College of Osteopathic Medicine Norwalk, CT USA
Kristi A. Sacco
Affiliation:
Department of Psychiatry Yale University School of Medicine New Haven, CT USA
Tony P. George
Affiliation:
Department of Psychiatry University of Toronto Faculty of Medicine Centre for Addiction and Mental Health (CAMH) Toronto, ON Canada
Peter Tyrer
Affiliation:
Imperial College of Science, Technology and Medicine, London
Kenneth R. Silk
Affiliation:
University of Michigan, Ann Arbor
Get access

Summary

Editor's note

Nicotine dependence is found in at least a billion people worldwide and in millions in the United States and Great Britain. It is a major cause of morbidity and mortality in all countries, and both active smoking and exposure to passive smoke has significant health care consequences. There currently are public health campaigns in both the UK and USA to combat smoking, and laws against smoking in public places are just one, if not one of the most visible, of the various public and community campaigns against smoking. While these campaigns are effective, most smokers wishing to quit will utilize pharmacological treatments which involve primarily nicotine replacement therapy (NRT) or the use of bupropion. Both have substantial evidence as to effectiveness, though there are other secondary pharmacological treatments that also are beginning to find some support such as vareniciline, clonidine and nortriptyline. The NRTs come in various forms from patches to nasal sprays to gum, inhalers, and lozenges. All have substantial support for their effectiveness. Cognitive-behavioural therapies, especially multi-modal interventions that are tailored to the specific patient, have a good deal of success and support for that success as well. Despite these effective interventions, smoking remains a major public health problem.

Introduction

Cigarette smoking is the single largest preventable cause of substantial morbidity and mortality in developed countries.

Type
Chapter
Information
Cambridge Textbook of Effective Treatments in Psychiatry , pp. 422 - 441
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abbot, N. C., Stead, L. F., White, A. R. & Barnes, J. (1998). Hypnotherapy for smoking cessation. Cochrane Database Systematic Reviews.CrossRefGoogle Scholar
Addington, J., el-Guebaly, N., Campbell, W., Hodgins, D. C. & Addington, D. (1998). Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry, 155(7), 974–6.CrossRefGoogle ScholarPubMed
Ahluwalia, J. S., Harris, K. J., Catley, D., Okuyemi, K. S. & Mayo, M. S. (2002). Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. Journal of the American Medical Association, 288(4), 468–74.CrossRefGoogle ScholarPubMed
Alterman, A. I., Gariti, P. & Mulvaney, F. (2001). Short- and long-term smoking cessation for three levels of intensity of behavioural treatment. Psychological Addictive Behavior, 15(3), 261–4.CrossRefGoogle Scholar
American Psychiatric Association (2006). Practice Guidelines for the Treatment of Patients with Substance Use Disorders, 2nd edn. Washington, DC: American Psychiatric Association.
Ascher, J. A., Cole, J. O., Colin, J. N.et al, (1995). Bupropion: A review of its mechanism of antidepressant activity. Journal of Clinical Psychiatry, 56, 395–401.Google ScholarPubMed
Baille, A., Mattick, R. P., Hall, W. & Webster, P. (1994). Meta-analytic review of the efficacy of smoking cessation interventions. Drug and Alcohol Review, 13, 157–70.CrossRefGoogle Scholar
Bakkevig, O., Steine, S., Hafenbradl, K. & Laerum, E. (2000). Smoking cessation. A comparative, randomized study between management in general practice and the behavioural programme SmokEnders. Scandinavian Journal of Primary Health Care, 18(4), 247–51.CrossRefGoogle ScholarPubMed
Balfour, D. J. K. & Fagerstrom, K. O. (1996). Pharmacology of nicotine and therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacological Therapy, 72, 51–81.CrossRefGoogle ScholarPubMed
Bartecchi, C. E., MacKenzie, T. D. & Schier, R. W. (1994). The human costs of tobacco use, part II. New England Journal of Medicine, 330, 975–80.CrossRefGoogle Scholar
Benowitz, N. (ed.) (1988). Toxicity of nicotine: implications with regard to nicotine replacement therapy. In Nicotine Replacement: A Critical Evaluation, ed. , P. C.Pomerleau, , Fagerstrom, K. O., Henningfield, J. E. & Hughes, J. R.. Alan R Liss: New York, pp. 187–217.Google Scholar
Berlin, I., Said, S., Spreux-Varoquaux, O.et al. (1995). A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clinical Pharmacological Therapy, 58, 444–52.CrossRefGoogle ScholarPubMed
Blondal, T., Franzon, M. & Westin, A. (1997). A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. European Respiratory Journal, 10, 1585–90.CrossRefGoogle ScholarPubMed
Bolliger, C. T., Zellweger, J. P., Danielsson, T.et al. (2000). Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. British Medical Journal, 321(7257), 329–33.CrossRefGoogle ScholarPubMed
Borland, R., Segan, C. J., Livingston, P. M. & Owen, N. (2001). The effectiveness of callback counseling for smoking cessation: a randomized trial. Addiction, 96(6), 881–9.CrossRefGoogle ScholarPubMed
Brown, R. A., Goldstein, M. G., Niaura, R., Emmons, K. M. & Abrams, D. B. (1993). Nicotine dependence: assessment and management. In Psychiatric Care of the Medical Patient, ed. Stoudemire, F. B.. New York: Oxford University Press, 877–901.Google Scholar
Brown, R. A., Kahler, C. W., Niaura, R.et al. (2001). Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology, 69(3), 471–80.CrossRefGoogle ScholarPubMed
Brown, R. A., Ramsey, S. E., Strong, D. R.et al. (2003). Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders. Tobacco Control, 12, 3019 Suppl.CrossRefGoogle ScholarPubMed
Burke, B. L., Arkowitz, H. & Menchola, M. (2003). The efficacy of motivational interviewing: a meta-analysis of controlled clinical trails. Journal of Consulting and Clinical Psychology, 71, 843–61.CrossRefGoogle Scholar
Burling, T. A., Burling, A. S. & Latini, D. A. (2001). A controlled smoking cessation trial for substance-dependent inpatients. Journal of Consulting and Clinical Psychology, 69(2), 295–304.CrossRefGoogle ScholarPubMed
Butler, C. C., Rollnick, S., Cohen, D., Russel, I., Bachmann, M. & Stott, N. (1999). Motivational consulting versus brief advice for smokers in general practice: a randomised trial. British Journal of General Practice, 49, 611–16.Google Scholar
Carpenter, M. J., Hughes, J. R., Solomon, L. J. & Callas, P. W. (2004). Both smoking reduction with nicotine replacement therapy and motivation advice increase future cessation among smokers unmotivated to quit. Journal of Consulting and Clinical Psychology, 72, 371–81.CrossRefGoogle Scholar
Carr, A. (2004). The Easy Way to Stop Smoking. New York: Sterling.Google Scholar
CDC (2002). Cigarette smoking among adults in the United States. 51, 300–3.
Cepeda-Benito, A. (1993). Meta-analysis review of the efficacy of nicotine chewing gum in smoking treatment programs. Journal of Consulting and Clinical Psychology, 61, 822–30.CrossRefGoogle ScholarPubMed
Chengappa, K. N. R., Kambhampati, R. K., Perkins, K.et al. (2001). Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants. Journal of Clinical Psychiatry, 62(7), 503–8.CrossRefGoogle ScholarPubMed
Clarke, P. B. S. (1991). Nicotinic receptor blockade therapy and smoking cessation. British Journal of Addiction, 86, 501–5.CrossRefGoogle ScholarPubMed
Colby, S. M., Monti, P. M., Barnett, N. P.et al. (1998). Brief motivational interviewing in a hospital setting for adolescent smoking: A preliminary study. Journal of Consulting and Clinical Psychology, 66, 574–8.CrossRefGoogle Scholar
Cornuz, J., Humair, J. P., Seematter, L.et al. (2002). Efficacy of resident training in smoking cessation: a randomized, controlled trial of program based on application of behavioral theory and practice with standardized patients. Annals of Internal Medicine, 136(6), 429–37.CrossRefGoogle ScholarPubMed
Covey, L. S. & Glassman, A. H. (1991). A meta-analysis of double-blind placebo controlled trials of clonidine for smoking cessation. British Journal of Addiction, 86, 991–8.CrossRefGoogle ScholarPubMed
Covey, L. S., Glassman, A. H. & Stetner, F. (1999). Naltrexone effects on short-term and long-term smoking cessation. Journal of Addictive Diseases, 18(1), 31–40.CrossRefGoogle ScholarPubMed
Covey, L. S., Sullivan, M. A., Johnston, A., Glassman, A. H., Robinson, M. D. & Adams, D. P. (2000). Advances in non-nicotine pharmacotherapy for smoking cessation. Drugs, 59(1), 17–31.CrossRefGoogle ScholarPubMed
Curry, S. (1993). Self-help interventions for smoking cessation. Journal of Consulting and Clinical Psychology, 61, 790–803.CrossRefGoogle ScholarPubMed
Curry, S. J., McBride, C., Grothaus, L. C., Louie, D., Wagner, E. H. (1995). A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers. Journal of Consulting and Clinical Psychology, 63(6), 1005–14.CrossRefGoogle ScholarPubMed
Dallery, J., Houtsmuller, E. J., Pickworth, W. B. & Stitzer, M. L. (2003). Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking. Psychopharmacology, 165, 172–80.CrossRefGoogle ScholarPubMed
Department of Health (1998). Smoking kills. A white paper on tobacco. London: The Stationery Office.
Dijkstra, A., Vries, H. & Roijackers, J. (1999). Targeting smokers with low readiness to change with tailored and nontailored self-helo materials. Preview Medicine, 28(2), 203–11.CrossRefGoogle ScholarPubMed
Doll, R., Peto, R., Wheatley, K., Gray, R. & Sutherland, I. (1994). Mortality in relation to smoking: 40 years' observations on male British doctors. British Medical Journal, 309, 901–11.CrossRefGoogle ScholarPubMed
Dornelas, E. A., Sampson, R. A., Gray, J. F., Waters, D. & Thompson, P. D. (2000). A randomized controlled trial of smoking cessation counseling after myocardial infarction. Preview Medicine, 30(4), 261–8.CrossRefGoogle ScholarPubMed
Dunn, C., Deroo, L. & Rivara, F. P. (2001). The use of brief interventions adapted from motivational interviewing across behavioural domains. Cochrane Database Systematic Review Addiction, 96(12), 1725–42.Google Scholar
Edwards, R. (2004). ABC of smoking. The problem of tobacco smoking. British Medical Journal, 328, 217–19.CrossRefGoogle Scholar
Ershoff, D. H., Quinn, V. P., Boyd, N. R., Stern, J., Gregory, M. & Wirtschafter, D. (1999). The Kaiser Permanente prenatal smoking cessation trial: When more isn't better, what is enough?American Journal of Preventive Medicine, 17, 161–8.CrossRefGoogle Scholar
Etter, J. F. & Perneger, T. B. (2001). Effectiveness of a computer-tailored smoking cessation program. Archives of Internal Medicine, 16(21), 2596–601.CrossRefGoogle Scholar
Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C. & Goff, D. C. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine and Tobacco Research, 3, 397–403.CrossRefGoogle Scholar
Evins, A. E., Cather, C., Deckersbach, T.et al. (2005). A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology, 25(3), 218–25.CrossRefGoogle Scholar
Fiore, M. C., Novotny, T. E., Pierce, J. P.et al. (1990). Methods used to quit smoking in the United States. Journal of American Medical Association, 263, 2760–5.CrossRefGoogle ScholarPubMed
Fiore, M. C., Jorenby, D. E., Baker, T. B. & Kenford, S. L. (1992). Tobacco dependence and the nicotine patch: clinical guidelines for effective use. Journal of the American Medical Association, 268, 2687–94.CrossRefGoogle ScholarPubMed
Fiore, M. C., Smith, S. S., Jorenby, D. E. & Baker, T. B. (1994). The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. Journal of the American Medical Association, 271(24), 1940–47.CrossRefGoogle ScholarPubMed
Fiore, M. C., Bailey, W. C., Cohen, S. J.et al. (2000). Clinical Practice Guideline: Treating Tobacco Use and Dependence. US Department of Health and Human Services, Rockville, MD: US Public Health Service.Google ScholarPubMed
Fiore, M. C., Hatsukami, D. K. & Baker, T. B. (2002). Effective tobacco dependence treatment. Journal of the American Medical Association, 288, 1768–71.CrossRefGoogle ScholarPubMed
Fisher, E. B. J., Lichtenstein, E., Haire-Joshu, D., Morgan, G. D. & Rehberg, H. R. (1993). Methods, successes, and failures of smoking cessation programs. Annual Reviews of Medicine, 44, 481–513.CrossRefGoogle ScholarPubMed
Foulds, J. (1996). Strategies for smoking cessation. British Medical Bulletin, 52, 1–17.CrossRefGoogle ScholarPubMed
Garcia, M. (2000). Evaluation of the amount of therapist contact in a smoking cessation program. Spanish Journal of Psychology, 3(1), 28–36.CrossRefGoogle Scholar
Garvey, A. J., Kinnunen, T., Nordstrum, B. L.et al. (2000). Effects of nicotine gum dose by level of nicotine dependence. Nicotine and Tobacco Research, 2, 53–63.Google ScholarPubMed
George, T. P., Ziedonis, D. M., Feingold, A.et al. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835–42.CrossRefGoogle Scholar
George, T. P., Vessicchio, J. C., Termine, A.et al. (2002). A placebo-controlled trial of bupropion for smoking cessation in schizophrenia. Biolological Psychiatry, 52, 53–61.CrossRefGoogle Scholar
George, T. P., Vessicchio, J. C., Termine, A., Jatlow, P. I., Kosten, T. R. & O'Malley, S. S. (2003). A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. Biological Psychology, 53 136–43.CrossRefGoogle ScholarPubMed
Giovino, G. A. (2002). Epidemiology of tobacco use in the United States. Oncogene, 21, 7326–40.CrossRefGoogle ScholarPubMed
Glasgow, R. (1987). Long-term effects of behavioral smoking cessation interventions. Behavior Therapy, 18, 297–324.CrossRefGoogle Scholar
Glasgow, R., Whitlock, E.Eakin, E. & Lichtstein, E. (2000). A brief smoking cessation intervention for women in low-income planned parenthood clinics. American Journal of Public Health, 90, 786–9.Google ScholarPubMed
Glassman, A. H. (1993a). Cigarette smoking: implications for psychiatric illness. American Journal of Psychiatry, 150, 546–53.Google Scholar
Glassman, A. H., Stetner, F., Walsh, B. T.et al. (1988). Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. Journal of the American Medical Association, 259(19), 2863–6.CrossRefGoogle ScholarPubMed
Glassman, A. H., Covey, L. S., Dalack, G. W.et al. (1993b). Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clinical Pharmacological Therapy, 54, 670–9.CrossRefGoogle Scholar
Glover, E. D., Sachs, D. P. L., Stitzer, M. L.et al. (1996). Smoking cessation in highly dependent smokers with 4 mg nicotine polacrilex. American Journal of Health Behavior, 20(5), 319–32.Google Scholar
Gonzales, D. H., Nides, M. A., Ferry, L. H.et al. (2001). Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clinical Pharmacology and Therapeutics, 69(6), 438–44.CrossRefGoogle ScholarPubMed
Gonzales, D., Rennard, S. I., Nides, M.et al. (2006). Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. Journal of the American Medical Association, 296(1), 47–55.CrossRefGoogle ScholarPubMed
Gourlay, S. G. & Benowitz, N. L. (1995). Is clonidine an effective smoking cessation therapy?Drugs, 50, 197–207.CrossRefGoogle ScholarPubMed
Gourlay, S. G., Stead, L. F. & Benowitz, N. L. (2001). Clonidine for smoking cessation. Cochrane Database Systematic Review. Oxford: Update Software Ltd.Google Scholar
Gritz, E. R., Nielsen, I. R. & Brooks, L. A. (1996). Smoking cessation and gender: the influence of physiological, psychological and beahvioral factors. Journal of the American Medical Women's Association, 51(1–2), 35–42.Google Scholar
Hajek, P., Taylor, T. Z. & Mills, P. (2002). Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: randomized controlled trial. British Medical Journal, 324(7329), 87–9.CrossRefGoogle Scholar
Hall, S. M., Munoz, R. F., Reus, V. I.et al. (1996). Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. Journal of Consulting and Clinical Psychology, 64(5), 1003–9.CrossRefGoogle ScholarPubMed
Hall, S. M., Reus, V. I., Munoz, R. F.et al. (1998). Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Archives of General Psychiatry, 55(8), 683–90.CrossRefGoogle ScholarPubMed
Hall, S. M., Humfleet, G. L., Reus, V. I., Munoz, R. F., Hartz, D. T. & Maude-Griffin, R. (2002). Psychological intervention and antidepressant treatment in smoking cessation. Archives of General Psychiatry, 59, 930–6.CrossRefGoogle ScholarPubMed
Hays, J. T., Hurt, R. D., Rigotti, N. A.et al. (2001). Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. Annals of Internal Medicine, 135, 423–33.CrossRefGoogle ScholarPubMed
Heatherton, T. F., Kozlowski, L. T.Frecker, R. C. & Fagerstrom, K. O. (1991). The Fagerstrom Test for Nicotine Dependence: a revsision of the Fagerstrom Tolerance Questionnaire. British Journal of Addictions, 86, 1119–27.CrossRefGoogle ScholarPubMed
Henningfield, J. E., Stapleton, J. M., Benowitz, N. L., Grayson, R. F. & London, E. D. (1993). Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Dependency, 33, 23–9.CrossRefGoogle ScholarPubMed
Herrera, N., Franco, R., Herrera, L., Partidas, A., Rolando, R. & Fagerstrom, K. O. (1995). Nicotine gum, 2 and 4 mg, for nicotine dependence. Chest, 108(2), 447–51.CrossRefGoogle ScholarPubMed
Hjalmarson, A., Franzon, M., Westin, A. & Wiklund, O. (1994). Effect of nicotine nasal spray on smoking cessation. Archives of Internal Medicine, 154, 2567–72.CrossRefGoogle ScholarPubMed
Hughes, J. R. (1989). Dependence potential and abuse liability of nicotine replacement therapies. Biomedical Pharmacotherapy, 43, 11–17.CrossRefGoogle ScholarPubMed
Hughes, J. R. (1991). Long-term use of nicotine-replacement therapy. In New Developments in Nicotine-Delivery Systems, ed. Henningfield, S. M., pp. 64–71. New York: Carlton.Google Scholar
Hughes, J. R. (1993). Risk/benefit of nicotine replacement in smoking cessation. Drug Safety, 8, 49–56.CrossRefGoogle Scholar
Hughes, J. R. (1994a). Non-nicotine pharmacotherapies for smoking cessation. Journal of Drug Developments, 6, 197–203.Google Scholar
Hughes, J. R. (1994b). An algorithm for smoking cessation. Archives of Family Medicine, 3, 280–5.CrossRefGoogle Scholar
Hughes, J. R. (1996a). Treatment of nicotine dependence. In Pharmacological Aspects of Drug Dependence: Toward an Integrative Neurobehavioral Approach. Handbook of Experimental Psychology Series, ed. Schuster, G. S. & Kuhar, M. J., pp. 599–618. New York: Springer-Verlag.CrossRefGoogle Scholar
Hughes, J. R. (1996b). The future of smoking cessation therapy in the United States. Addiction, 91(12), 1797–802.CrossRefGoogle Scholar
Hughes, J. R. & Francis, R. J. (1994). Behavioral support programs for smoking cessation. Modern Medicine, 62, 22–6.Google Scholar
Hughes, J. R. & Francis, R. J. (1995). How to help psychiatric patients stop smoking. Psychiatric Services, 46, 435–45.Google ScholarPubMed
Hughes, J. R., Stead, L. F. & Lancaster, T. (2003). Antidepressants for smoking cessation. Cochrane Database Systematic Review. Oxford: Update Software Ltd.Google Scholar
Hurt, R. D., Sachs, D. P. L., Glover, E. D.et al. (1997). A comparison of sustained release bupropion and placebo for smoking cessation. New England Journal of Medicine 337(17), 1195–202.CrossRefGoogle ScholarPubMed
Irvin, J., Hendricks, P. S. & Brandon, T. H. (2003). The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials. Nicotine and Tobacco Research, 5, 27–35.CrossRefGoogle ScholarPubMed
Jackson, P., Stapleton, J., Russell, M. & Merriman, R. (1986). Predictors of outcome in a general practitioner intervention against smoking. Previews of Medicine, 5, 244–53.CrossRefGoogle Scholar
Jorenby, D. E., Leischow, S. J., Nides, M. A.et al. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine, 340(9), 685–91.CrossRefGoogle ScholarPubMed
Jorenby, D. E., Hays, J. T., Rigotti, N. A.et al. (2006). Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. Journal of the American Medical Association, 296(1), 56–63.CrossRefGoogle ScholarPubMed
Kalman, D., Hayes, K., Colby, S. M., Eaton, C. A., Rohsenow, D. J. & Monti, P. M. (2001). Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery: a pilot study. Journal of Substance Abuse Treatment, 20, 233–8.CrossRefGoogle ScholarPubMed
Kalman, D., Morrisette, S. B. & George, T. P. (2005). Co-morbidity of smoking in psychiatric and substance use disorders. American Journal on Addictions, 14, 106–23.CrossRefGoogle ScholarPubMed
Kornitzer, M., Boutsen, M., Dramaix, M., Thijs, J. & Gustavsson, G. (1995). Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Preventive Medicine, 24, 41–7.CrossRefGoogle ScholarPubMed
Krishnan-Sarin, S., Meandjiza, B. & O'Malley, S. S. (2003). Nicotine patch and naltrexone for smoking cessation: a preliminary study. Nicotine and Tobacco Research, 5(6), 851–7.CrossRefGoogle ScholarPubMed
Lader, D. & Meltzer, H. (2000). Smoking related behaviour and attitudes. Office of National Statistics, UK.
Lancaster, T. & Stead, L. F. (1999a).Individual behavioural counselling for smoking cessation. Cochrane Database Systematic Review.Google Scholar
Lancaster, T. & Stead, L. F. (1999b). Self help interventions for smoking cessation. Cochrane Database Systematic Review. Oxford: Update Software Ltd.Google Scholar
Lancaster, T. & Stead, L. F. (2002). Mecamylamine (a nicotine antagonist) for smoking cessation. Cochrane Database Systematic Review. Oxford: Update Software Ltd.Google Scholar
Lancaster, T., Silagy, C. & Fowler, G. (2000). Training Health Professionals in smoking cessation. Cochrane Database Systematic Review. Oxford: Update Software Ltd.Google Scholar
Lasser, K., Boyd, J. W., Woolhander, S., Himmelstein, D. U., McCormick, D. & Bor, D. H. (2000). Smoking and mental illness: a population-based prevalence study. Journal American Medical Association, 284, 2606–10.CrossRefGoogle ScholarPubMed
Law, M. & Tang, J. L. (1995). An analysis of the effectiveness of interventions intended to help people stop smoking. Archives of Internal Medicine, 155, 1933–41.CrossRefGoogle ScholarPubMed
Leischow, S. J. (1994). Nicotine vaporiser: review of results. In Future Directions in Nicotine Replacement Therapy, pp. 99–103. Chester, UK: Adis.Google Scholar
Lovato, C., Linn, G., Stead, L. F. & Best, A. (2003). Impact of tobacco advertising and promotion on increasing adolescent smoking behaviour. Cochrane Database Systematic Review. Oxford: Update Software Ltd.Google Scholar
McChargue, D. E., Gulliver, S. B. & Hitsman, B. (2001). Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?Addiction, 97, 785–93.CrossRefGoogle Scholar
Mermelstein, R. J., Karnatz, T. & Reichmann, S. (1992). Smoking. In Principles and Practice of Relapse Prevention, ed. Wilson, P. H., pp. 43–68. New York: Guilford Press.Google Scholar
Miller, W. R. (2004). Motivational interviewing in service to health promotion. American Journal of Health Promotion, 18, A1–A10.Google Scholar
Miller, W. R. & Rollnick, S. (2002). Motivational Interviewing: Preparing People for Change, 2nd edn. New York: Guilford Press.Google Scholar
Moher, M., Hey, K. & Lancaster, T. (2003). Workplace interventions for smoking cessation. Cochrane Database Systematic Review. Oxford: Update Software Ltd.Google Scholar
Nana, A. & Praditsuwan, R. (1998). Clonidine for smoking cessation. Journal of Medical Association of Thailand, 81(2), 87–93.Google ScholarPubMed
Niaura, R., Brown, R. A., Goldstein, M. G., Murphy, J. K. & Abrams, D. B. (1996). Transdermal clonidine for smoking cessation: a double-blind randomized dose-response study. Experimental and Clinical Psychopharmacology, 4(3), 285–91.CrossRefGoogle Scholar
Niaura, R., Britt, D. M., Shadel, W. M., Goldstein, M., Abrams, D. & Brown, R. (2001). Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychological Addictive Behaviour, 15(1), 13–17.CrossRefGoogle Scholar
NICE (2002). Guidance on the use of nicotine replacement therapy (NRT) & Bupropion for smoking cessation. TA39, ISBN: 1–84257-163-x. National Institute for Clinical Excellence, UK.
Noonan, W. & Moyers, T. (1997). Motivational interviewing: a review. Journal of Substance Misuse, 2, 8–16.CrossRefGoogle Scholar
O'Malley, S. S., Cooney, J. L., Krishnan-Sarin, S.et al. (2006). A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Archives of Internal Medicine, 166(6), 667–74.CrossRefGoogle ScholarPubMed
Palmer, K. J. & Faulds, D. (1992). Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as an aid to smoking cessation. Drugs, 44, 498–529.CrossRefGoogle ScholarPubMed
Parrott, S., Godfrey, C., Raw, M., West, M., West, R. & McNeill, A. (1998). Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax, 53 (Suppl. 5, Part 2).Google ScholarPubMed
Patten, C. A., Martin, J. E., Myers, M. G., Calfas, K. J. & Williams, C. D. (1998). Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression. Journal of Studies of Alcohol, 59(3), 327–35.CrossRefGoogle ScholarPubMed
Perkins, K. A., Grobe, J. E., Stiller, R. L., Fonte, C. & Goettler, J. E. (1992). Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clinical and Pharmacological Therapy, 52, 627–34.CrossRefGoogle ScholarPubMed
Perkins, K. A., Grobe, J. E., Caggiula, A., Wilson, A. S. & Stiller, R. L. (1997). Acute reinforcing effects of low-dose nicotine nasal spray in humans. Pharmacology, Biochemistry and Behavior, 56(2), 235–41.CrossRefGoogle ScholarPubMed
Perkins, K. A., Donny, E. & Caggiula, A. R. (1999). Sex-differences in nicotine effects and self-administration: review of human and animal evidence. Nicotine and Tobacco Research, 1, 301–15.CrossRefGoogle ScholarPubMed
Perkins, K. A., Marcus, M. D., Levine, M. D.et al. (2001). Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. Journal of Consulting and Clinical Psychology, 69(4), 604–13.CrossRefGoogle ScholarPubMed
Platt, S., Tannahill, A., Watson, J. & Fraser, E. (1997). Effectiveness of antismoking telephone helpline: follow up survey. British Medical Journal, 314, 1371–5.CrossRefGoogle ScholarPubMed
Pomerleau, O. F. & Pomerleau, C. S. (1984). Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neuroscience Biobehavior Reviews, 8, 503–13.CrossRefGoogle ScholarPubMed
Prochazka, A. V., Weaver, M. J., Keller, R. T., Fryer, G. E., Licari, P. A. & Lofaso, D. (1998). A randomized trial of nortriptyline for smoking cessation. Archives of Internal Medicine, 158, 2035–9.CrossRefGoogle ScholarPubMed
Reid, R. D., Pipe, A. & Dafoe, W. A. (1999). Is telephone counseling a useful addition to physician advice and nicotine replacement therapy in helping patients to stop smoking? A randomized controlled trial. Canadian Medical Associative Journal, 160(1), 1577–81.Google ScholarPubMed
Resnicow, K., DiIorio, C., Soet, J. E., Borrelli, B., Hecht, J. & Ernst, D. (2002). Movitational interviewing in health promotion: It sounds like something is changing. Health Psychology, 21, 444–51.CrossRefGoogle ScholarPubMed
Richmond, R. L. (1997). A comparison of measures used to assess effectiveness of the transdermal nicotine patch at 1 year. Addictive behaviours, 22(6), 753–7.CrossRefGoogle ScholarPubMed
Rigotti, N. A. (2002). Treatment of tobacco use and dependence. New England Journal of Medicine, 346, 506–12.CrossRefGoogle ScholarPubMed
Rigotti, N. A., Arnsten, J. H., McKool, K. M., Wood-Reid, K. M., Pasternak, R. C. & Singer, D. E. (1997). Efficacy of a smoking cessation program for hospital patients. Archives in Internal Medicine, 157(22), 2653–60.CrossRefGoogle ScholarPubMed
Roddy, E. (2004). ABC of smoking cessation. Bupropion and other non-nicotine pharmacotherapies. British Medical Journal, 328, 509–11.CrossRefGoogle Scholar
Rose, J. E. & Behm, F. M. (1987). Refined cigarette smoke as a method for reducing nicotine intake. Pharmacological and Biochemical Behaviour, 28, 305–10.CrossRefGoogle ScholarPubMed
Rose, J. E. & Levin, E. D. (1991). Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence. Pharmacological and Biochemical Behaviour, 41, 219–26.CrossRefGoogle Scholar
Rose, J. E., Behm, F. M., Westman, E. C., Levin, E. D., Stein, R. M. & Ripka, G. V. (1994). Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicontine patch treatment alone. Clinical and Pharmacological Therapy, 56, 86–99.CrossRefGoogle Scholar
Rose, J. E., Behm, F. M. & Westman, E. C. (1998). Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy. Experimental and Clinical Psychopharmacology, 6(3), 331–43.CrossRefGoogle ScholarPubMed
Royal College of Physicians (RCP) (2002). Protecting smokers, saving lives: the case for a tobacco and nicotine regulatory authority. London: RCP.
Russell, M. A. H., Jarvis, M. J., Sutherland, G. & Feyerabend, C. (1987). Nicotine replacement in smoking cessation. Journal of the American Medical Association, 257, 3262–65.CrossRefGoogle ScholarPubMed
Sachs, D. P. L. (1995). Effectiveness of the 4-mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers. Archives of Internal Medicine, 155(18), 1973–80.CrossRefGoogle ScholarPubMed
Sachs, D. P. L. (1991). Advances in smoking cessation treatment. Current Pulmonology, 12, 139–98.Google Scholar
Sampablo, L. I., Carreras, J. M., Lores, L., Quesada, M. & Sanchez, A. L. (2002). Smoking cessation and bupropion: anxiety and depression as predictors of therapeutic efficacy. Archivos de Bronconeumologaia, 38(8), 351–5.Google Scholar
Schneider, N. G., Olmstead, R., Mody, F. V.et al. (1995). Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. Addiction, 90, 1671–82.CrossRefGoogle ScholarPubMed
Schneider, N. G., Olmstead, R., Nilsson, F., Mody, F. V., Franzon, M. & Doan, K. (1996). Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo controlled trial. Addiction, 91(9), 1293–306.CrossRefGoogle ScholarPubMed
Schwartz, J. L. (1992). Methods of smoking cessation. Medical Clinics of North America, 76, 451–76.CrossRefGoogle ScholarPubMed
Shiffman, S., Dresler, C. M., Hajek, P., Gilburt, S. J. A., Targett, D. A. & Strahs, K. R. (2002). Efficacy of a nicotine lozenge for smoking cessation. Archives of Internal Medicine, 162(11), 1267.CrossRefGoogle ScholarPubMed
Silagy, C., Mant, D., Fowler, G. & Lodge, M. (1994). Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet, 343, 139–42.CrossRefGoogle ScholarPubMed
Silagy, C., Lancaster, T., Stead, L., Mant, D. & Fowler, G. (2002). Nicotine replacement for smoking cessation. Cochrane Database Systematic Review. Oxford: Update Software Ltd.Google Scholar
Slemmer, J. E., Martin, B. R. & Damaj, M. I. (2000). Bupropion is a nicotinic antagonist. Journal of Pharmacological Experimental Therapy, 295, 321–7.Google ScholarPubMed
Sowden, A., Arblaster, L. & Stead, L. (2002). Community interventions for preventing smoking in young people. Cochrane Database Systematic Review. Oxford: Update Software Ltd.Google Scholar
Stolerman, I. P., Goldfarb, T., Fink, R. & Jarvik, M. E. (1973). Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia, 28, 247–59.CrossRefGoogle ScholarPubMed
Stotts, A. M., DiClemente, C. C. & Dolen-Mullen, P. (2002). One-to-one – a motivational intervention for resistant pregnant smokers. Addictive Behaviors, 27, 275–92.CrossRefGoogle ScholarPubMed
Sutherland, G., Russell, M. A. H., Stapleton, J., Feyerabend, C. & Ferno, O. (1992). Nasal nicotine spray: a rapid nicotine delivery system. Psychopharmacology (Berlin), 108, 512–18.CrossRefGoogle ScholarPubMed
Sutherland, G., Russell, M. A. H., Stapleton, J. & Feyerabend, C. (1993). Glycerol particle cigarettes: a less harmful option for chronic smokers. Thorax, 48, 385–7.CrossRefGoogle ScholarPubMed
Sutherland, G., Stapleton, J. A., Russell, M. A. H. & Feyerabend, C. (1995). Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology (Berlin), 120, 418–25.CrossRefGoogle ScholarPubMed
Tappin, D. M., Lumsden, M. A., McIntyre, D.et al. (2000). A pilot study to establish a randomized trial methodology to test the efficacy of a behavioural intervention. Health Education Research, 15, 491–502.CrossRefGoogle ScholarPubMed
Tashkin, D. P., Kanner, R., Bailey, W.et al. (2001). Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet, 357, 1571–5.CrossRefGoogle ScholarPubMed
Tonnesen, P., Norregaard, J., Mikkelsen, K., Jorgensen, S. & Nilsson, F. (1993). A double-blind trial of a nicotine inhaler for smoking cessation. Journal of the American Medical Association, 269, 1268–71.CrossRefGoogle ScholarPubMed
Tonstad, S., Tønnesen, P., Hajek, P., Williams, K. E., Billing, C. B. & Reeves, K. R. (2006). Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. Journal of the American Medical Association, 296(1), 64–71.CrossRefGoogle ScholarPubMed
US Department of Health and Human Services (1988). Treatment of tobacco dependence. In The Health Consequences of Smoking: Nicotine Addiction, pp. 459–560. Washington, DC: US Government Printing Office.
Viswesvaran, C. & Schmidt, F. L. (1992). A meta-analytic comparison of the effectiveness of smoking cessation methods. Journal of Applied Psychology, 77, 554–61.CrossRefGoogle ScholarPubMed
Wallstrom, M., Nilsson, F. & Hirsch, J. M. (2000). A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction, 95(8), 1161–71.CrossRefGoogle ScholarPubMed
West, R. & Shiffman, S. (2001). Effects of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacologia, 155(2), 115–22.CrossRefGoogle ScholarPubMed
West, R., Hajek, P., Foulds, J., Nilsson, F., May, S. & Meadows, A. (2000). A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacologia, 149(3), 198–202.CrossRefGoogle ScholarPubMed
Wetter, D. W., Fiore, M. C., Baker, T. B. & Young, T. B. (1995). Tobacco withdrawal and nicotine replacement influence objective measures of sleep. Journal of Consulting and Clinical Psychology, 63, 658–67.CrossRefGoogle Scholar
White, A. R., Rampes, H. & Ernst, E. (2002). Acupunture for smoking cessation. Cochrane Database review. Oxford: Update Software Ltd.Google Scholar
Ziedonis, D. M. & George, T. P. (1997). Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schiophrenia Bulletin, 23(2), 247–54.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Treatment of nicotine dependence
    • By Andrea H. Weinberger, Department of Psychiatry Yale University Medical School of Medicine New Haven, CT USA, Pamela Walters, Camlet Lodge Regional Secure Unit Chase Farm Hospital The Ridgeway Enfield London UK, Taryn M. Allen, Department of Psychiatry Yale University School of Medicine USA, Melissa M. Dudas, New York College of Osteopathic Medicine Norwalk, CT USA, Kristi A. Sacco, Department of Psychiatry Yale University School of Medicine New Haven, CT USA, Tony P. George, Department of Psychiatry University of Toronto Faculty of Medicine Centre for Addiction and Mental Health (CAMH) Toronto, ON Canada
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.025
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Treatment of nicotine dependence
    • By Andrea H. Weinberger, Department of Psychiatry Yale University Medical School of Medicine New Haven, CT USA, Pamela Walters, Camlet Lodge Regional Secure Unit Chase Farm Hospital The Ridgeway Enfield London UK, Taryn M. Allen, Department of Psychiatry Yale University School of Medicine USA, Melissa M. Dudas, New York College of Osteopathic Medicine Norwalk, CT USA, Kristi A. Sacco, Department of Psychiatry Yale University School of Medicine New Haven, CT USA, Tony P. George, Department of Psychiatry University of Toronto Faculty of Medicine Centre for Addiction and Mental Health (CAMH) Toronto, ON Canada
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.025
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Treatment of nicotine dependence
    • By Andrea H. Weinberger, Department of Psychiatry Yale University Medical School of Medicine New Haven, CT USA, Pamela Walters, Camlet Lodge Regional Secure Unit Chase Farm Hospital The Ridgeway Enfield London UK, Taryn M. Allen, Department of Psychiatry Yale University School of Medicine USA, Melissa M. Dudas, New York College of Osteopathic Medicine Norwalk, CT USA, Kristi A. Sacco, Department of Psychiatry Yale University School of Medicine New Haven, CT USA, Tony P. George, Department of Psychiatry University of Toronto Faculty of Medicine Centre for Addiction and Mental Health (CAMH) Toronto, ON Canada
  • Edited by Peter Tyrer, Imperial College of Science, Technology and Medicine, London, Kenneth R. Silk, University of Michigan, Ann Arbor
  • Book: Cambridge Textbook of Effective Treatments in Psychiatry
  • Online publication: 12 May 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544392.025
Available formats
×